Innovations Advanced by M&A - Partnership for the US Life Science Ecosystem (PULSE)

Innovations Advanced by M&A: Opdivo and Yervoy’s Substantial Impact on Cancer Treatment

May 15, 2024 | Blog Post, Innovations Advanced by M&A

This blog is another installment in a series, Innovations Advanced by M&A, that underscores the importance of mergers and acquisitions in ensuring a competitive and vibrant biopharmaceutical landscape for patients. You can find previous blogs in this series here:...

Innovations Advanced by M&A: The First Therapy for Pompe Disease

May 1, 2024 | Blog Post, Innovations Advanced by M&A

This blog is another installment in our series, Innovations Advanced by M&A, which underscores the importance of mergers and acquisitions in ensuring a competitive and vibrant biopharmaceutical landscape for patients. You can find previous blogs in this series...

Innovations Advanced by M&A: A Cure for Inherited Blindness

Apr 18, 2024 | Blog Post, Innovations Advanced by M&A

This blog is the first installment in a series, Innovations Advanced by M&A, that underscores the importance of mergers and acquisitions in ensuring a competitive and vibrant biopharmaceutical landscape for patients. Across the United States’ world-class life...